Board of Directors
PAUL AUWAERTER, MD, MBA, FIDSA
Johns Hopkins University
Dr. Paul Auwaerter is a professor of medicine at the Johns Hopkins University School of Medicine. His areas of clinical expertise include Lyme disease, Epstein-Barr virus and fever of unknown origin.
Dr. Auwaerter serves as the clinical director of the Division of Infectious Diseases. He is also the director of the Fisher Center for Environmental Infectious Diseases and the chief medical officer of the Point of Care-Information Technology (POC-IT) Center. He earned his medical degree from the Columbia University College of Physicians and Surgeons. His research interests include tick-borne diseases and point of care information technology.
Dr. Auwaerter serves on the Clinical Compensation Subcommittee for the Johns Hopkins Department of Medicine. He was recognized with a Healthnetworks Service Excellence Award in 2014. He is a member of the American Society of Microbiology and the Infectious Diseases Society of America.
Dial hewlett, Jr., MD, fidsa
Westchester County Department of Health
Dr. Dial Hewlett, Jr. was recruited to attend the University of Wisconsin as an undergraduate on a track scholarship and went on to receive his medical degree from the university in 1976. He completed an internal medicine residency at Harlem Hospital Center – Columbia University College of Physicians & Surgeons in New York City. He then served for an additional year as chief medical resident at Harlem Hospital Center. Following internal medicine training, Dr. Hewlett completed a two-year clinical and research fellowship in infectious diseases at Montefiore Medical Center and Albert Einstein Affiliated Hospitals in the Bronx, New York.
Following completion of post-graduate medical training, Dr. Hewlett was appointed to be chief of the Infectious Disease Division at Lincoln Medical & Mental Health Center in the Bronx, New York, and assistant professor of medicine at New York Medical College. He subsequently became an associate professor of clinical medicine and served for a total of nine years at Lincoln prior to joining the pharmaceutical industry at the end of 1996.
During his 23-year career in the pharmaceutical industry with Pfizer Inc., Dr. Hewlett simultaneously served on the voluntary medical staff as an infectious diseases consultant at Lawrence Hospital and as an infectious diseases consultant and co-chair of infection control at Calvary Hospital in the Bronx, New York.
Following retirement from the pharmaceutical industry in June 2019, Dr. Hewlett accepted a position as medical director of disease control and deputy to the commissioner at Westchester County Department of Health. In this position, he has served as chief of tuberculosis services, and since March 2020, he has supported health department activities aimed at COVID-19 prevention, including the COVID-19 mass vaccination initiatives for adults and children.
Dr. Hewlett is a fellow of the American College of Physicians, the Infectious Disease Society of America and the New York Academy of Medicine. He is the recipient of an Infectious Diseases of America Citation Award in 2021. He currently serves on the board of directors for Calvary Hospital and is a member of the National Medical Association Task Force on COVID-19 Vaccines.
Jeanne marrazzo, MD, mph, FIDSA
University of Alabama at Birmingham
Dr. Jeanne Marrazzo is the C. Glenn Cobbs Endowed Chair in Infectious Diseases and director of the Division of Infectious Diseases at the University of Alabama at Birmingham, where she also co-directs the Center for AIDS Research. Her research focuses on the management and prevention of sexually transmitted infections, the vaginal microbiome and reproductive tract infections in women. Dr. Marrazzo has been involved in IDSA leadership for the last decade, first through membership on the IDWeek Program Committee, and more recently as a member of the board for the past four years. Through this service, she has gained a deep understanding of, and helped to promote, IDSA’s goals in numerous areas.
SARAH S. LONG, MD, FIDSA
St. Christopher’s Hospital for Children
Dr. Sarah S. Long is a pediatric infectious disease specialist in Philadelphia, Pennsylvania, and is affiliated with St. Christopher’s Hospital for Children. She received her medical degree from Sidney Kimmel Medical College and has been in practice for more than 20 years.
ELIOT W. GODOFSKY, MD, FACP, FIDSA
Bach & Godofsky
Dr. Eliot W. Godofsky is an infectious diseases specialist in Bradenton, Florida, and is affiliated with multiple hospitals in the area, including Blake Medical Center and Manatee Memorial Hospital. He received his medical degree from Georgetown University School of Medicine and has been in practice for more than 20 years.
BARBARA E. MURRAY, MD, fidsa
University of Texas Health Science Center
Dr. Barbara E. Murray is the J. Ralph Meadows Professor of Medicine of the ID division. She is a 1969 cum laude graduate in mathematics from Rice University in Houston, Texas, (selected as a Rice Distinguished Alumna in 2015) and graduated first in her class (Ho Din Award) from the University of Texas Southwestern Medical School in Dallas in 1973.
She then spent six years training in internal medicine and infectious diseases at Harvard Medical School’s Massachusetts General Hospital in Boston, followed by six months in Thailand conducting research at the Armed Forces Research Institute of Medical Sciences. She joined the faculty at McGovern Medical School at the University of Texas Health Science Center at Houston (UTHealth) as an assistant professor in 1980 and became a professor in 1990, director of the Division of Infectious Diseases in 1995 and the J. Ralph Meadows Professor in 2003.
Dr. Murray is a nationally and internationally recognized expert in antibiotic resistance, enterococci and enterococcal infections and bacterial pathogenesis. She conducts NIH-funded basic and translational research (including a prestigious 10-year MERIT award), has served on numerous NIH committees, DSMBs and study sections, including as past chair of the NIH Recombinant DNA Advisory Committee, as well as on the FDA’s Anti-Infectives Advisory Committee. She has also served as a consultant to the pharmaceutical industry, to the European Food Safety Authority and to the EU’s Innovative Medicine’s Initiative.
She has been active in professional societies, including serving on the Program Planning Committee of the American Society of Microbiology’s ICAAC meeting for nine years and as the chair for three years; as an editor of Antimicrobial Agents and Chemotherapy, a journal published by the American Society of Microbiology (10-year term); on the Program Committee of the European Congress of Clinical Microbiology and Infectious Diseases (ECCMID); and she is a past secretary, treasurer and president of the Infectious Diseases Society of America and is currently chair of the IDSA Antimicrobial Resistance Committee. Dr. Murray is a frequent visiting professor at other medical schools and a frequent invited speaker at national and international meetings. She received the IDSA Alexander Fleming Award for lifetime achievements in 2017.
STEPHEN CALDERWOOD, MD, FIDSA
Massachusetts General Hospital
Dr. Stephen Calderwood is emeritus chief of the Infectious Diseases Division at Massachusetts General Hospital and the Morton N. Swartz, MD, Academy Professor of Medicine (Microbiology and Immunobiology) at Harvard Medical School. During his 27-year tenure as the chief of infectious diseases, he oversaw the clinical and research training of more than 200 fellows training in infectious diseases and also ran a research lab that was continuously funded by the NIH. Dr. Calderwood also served as president of the Infectious Diseases Society of America from 2014 to 2015. Dr. Calderwood graduated from the Harvard Medical School in 1975.
CHRIStopher BUSKY, CAE
CHIEF EXECUTIVE OFFICER
Christopher Busky, CAE, is the chief executive officer of the Infectious Diseases Society of America (IDSA) and the IDSA Foundation.
IDSA, based in Arlington, VA, represents more than 12,000 infectious diseases physicians, scientists and advanced practice providers devoted to patient care, prevention, public health, education and research in the area of infectious diseases. The society is a leader on issues of importance to ID professionals, including education and training, policy and advocacy, setting guidelines for patient care and developing resources for clinical practice. IDSA is recognized for its sponsorship of the premier IDWeek annual conference and top-quality journals, and it has been at the forefront of global health issues such as antimicrobial resistance and HIV. Housed within IDSA is the HIV Medicine Association (HIVMA), which represents medical providers and researchers working on the front lines of HIV. IDSA and HIVMA members work across the United States and in nearly 100 other countries on six continents.
Prior to joining IDSA, Busky spent 10 years as the executive vice president and chief operating officer for the Heart Rhythm Society, an international medical society that represents health care professionals who specialize in the prevention and treatment of heart rhythm disorders. He has more than 30 years of nonprofit management experience.
Chis currently serves on the American Society of Association Executives’ Key Professional Association Committee.